Do animal models of vein graft atherosclerosis predict outcomes in man?

Atherosclerosis

Volumn 223, Issue 1, 2012, Pages 102-105

  Yazdani, Saami K ^a   Otsuka, Fumiyuki ^a   Nakano, Masataka ^a   Finn, Aloke V ^b   Virmani, Renu ^a  

^a CVPATH INSTITUTE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Pathology; Saphenous vein bypass graft; Statin

Indexed keywords

ATHEROSCLEROSIS; EXPERIMENTAL MODEL; HUMAN; NONHUMAN; NOTE; POSTOPERATIVE COMPLICATION; PREDICTOR VARIABLE; PRIORITY JOURNAL; SAPHENOUS VEIN; TREATMENT OUTCOME; VEIN GRAFT;

ANIMALS; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; JUGULAR VEINS; PYRROLES; VASCULAR GRAFTING;

EID: 84863097890     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.04.028     Document Type: Note

References (13)

1. Hamby R.I., Aintablian A., Handler M., Voleti C., Weisz D., Garvey J.W., et al. Aortocoronary saphenous vein bypass grafts. Long-term patency, morphology and blood flow in patients with patent grafts early after surgery. Circulation 1979, 60:901-909.
2. Virmani R., Atkinson J.B., Forman M.B. Aortocoronary saphenous vein bypass grafts. Cardiovasc Clin 1988, 18:41-62.
3. Glagov S., Weisenberg E., Zarins C.K., Stankunavicius R., Kolettis G.J. Compensatory enlargement of human atherosclerotic coronary arteries. New Engl J Med 1987, 316:1371-1375.
4. Butany J.W., David T.E., Ojha M. Histological and morphometric analyses of early and late aortocoronary vein grafts and distal anastomoses. Can J Cardiol 1998, 14:671-677.
5. Yazdani SK, Farb A, Nakano M, Vorpahl M, Ladich E, Finn AV, et al. Pathology of drug-eluting versus bare metal stents in saphenous vein bypass graft Lesions. JACC Cardiovasc interven 2012;in press.
6. Qiang B., Toma J., Fujii H., Osherov A.B., Nili N., Sparkes J.D., et al. Statin therapy prevents expansive remodeling in venous bypass grafts. Atherosclerosis 2012, 223(1):106-113.
7. Kolodgie F.D., Gold H.K., Burke A.P., Fowler D.R., Kruth H.S., Weber D.K., et al. Intraplaque hemorrhage and progression of coronary atheroma. New Engl J Med 2003, 349:2316-2325.
8. Burke A.P., Kolodgie F.D., Farb A., Weber D., Virmani R. Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation 2002, 105:297-303.
9. Stein E.A., Mellis S., Yancopoulos G.D., Stahl N., Logan D., Smith W.B., et al. Effect of a monoclonal antibody to PCSK9 on LDL cholesterol. New Engl J Med 2012, 366:1108-1118.
10. Hata M., Takayama T., Sezai A., Yoshitake I., Hirayama A., Minami K. Efficacy of aggressive lipid controlling therapy for preventing saphenous vein graft disease. Ann of Thorac Surg 2009, 88:1440-1444.
11. Kulik A., Voisine P., Mathieu P., Masters R.G., Mesana T.G., Le May M.R., et al. Statin therapy and saphenous vein graft disease after coronary bypass surgery: analysis from the CASCADE randomized trial. Ann Thorac Surg 2011, 92:1284-1291.
12. Kulik A., Ruel M. Lipid-lowering therapy and coronary artery bypass graft surgery: what are the benefits?. Current Opinion in Cardiology 2011, 26:508-517.
13. Nicholls S.J., Brewer H.B., Kastelein J.J., Krueger K.A., Wang M., Shao M., et al. Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial. JAMA - J Am Med Assoc 2011, 306:2099-2109.